Jacopo Galvanin
Overview
Explore the profile of Jacopo Galvanin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Milana F, Procopio F, Calafiore E, Famularo S, Costa G, Galvanin J, et al.
Ann Surg Oncol
. 2025 Feb;
PMID: 40019600
Background: R0 resection is the standard for mass-forming cholangiocarcinoma (MFCCC). R1vasc resection (tumor-vessel detachment) yielded results comparable to R0 and superior to parenchymal-tumor exposure (R1par) for hepatocellular carcinoma and colorectal...
2.
Procopio F, Galvanin J, Mauri G, Famularo S, Pedicini V, Milana F, et al.
Surgery
. 2025 Jan;
180():109138.
PMID: 39854785
Background: Communicating vessels among hepatic veins in patients with tumors invading/compressing hepatic veins at their caval confluence facilitate new surgical solutions. Although their recognition by intraoperative ultrasound has been described,...
3.
Procopio F, Mauri G, Milana F, Braciforte B, Galvanin J, Costa G, et al.
Ann Surg Oncol
. 2024 Mar;
31(7):4445-4446.
PMID: 38519782
Background: Minimally invasive anatomical resection (AR) for posterosuperior lesions is technically challenging. The Glissonean approach or puncture technique is generally selected. The tumor-feeding portal pedicle compression AR (C-AR) is an...
4.
Procopio F, Branciforte B, Galvanin J, Costa G, Franchi E, Cimino M, et al.
Surg Endosc
. 2023 Nov;
38(1):193-201.
PMID: 37957299
Background: Segmental or subsegmental anatomical resection (AR) of hepatocellular carcinoma (HCC) in minimal access liver surgery (MALS) has been technically proposed. The Glissonean approach or dye injection technique are generally...
5.
Galvanin J, Sommacale D, Brustia R
J Visc Surg
. 2023 Sep;
160(5):384-385.
PMID: 37758598
No abstract available.
6.
Del Fabbro D, Procopio F, Galvanin J, Costa G, Famularo S, Palmisano A, et al.
Hepatobiliary Pancreat Dis Int
. 2023 Jul;
23(4):417-420.
PMID: 37516588
No abstract available.
7.
Famularo S, Milana F, Cimino M, Procopio F, Costa G, Galvanin J, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765743
Disease progression (PD) at neoadjuvant chemotherapy for patients with colorectal liver metastases (CLMs) is considered a contraindication to hepatic resection. Our aim was to estimate the overall survival (OS) in...
8.
Milana F, Galvanin J, Sommacale D, Brustia R
Updates Surg
. 2022 Oct;
74(6):2019-2021.
PMID: 36258140
No abstract available.
9.
Del Fabbro D, Galvanin J, Torzilli G
Minerva Surg
. 2022 Mar;
77(5):441-447.
PMID: 35230039
Surgical resection remains the gold standard for the treatment of colorectal liver metastases (CLM). The goal for successful surgery is to pursue the optimal balance between oncological radicality and adequate...
10.
Vigano L, Gentile D, Galvanin J, Corleone P, Costa G, Cimino M, et al.
J Gastrointest Surg
. 2021 Sep;
26(3):570-582.
PMID: 34508293
Background: Liver resection for colorectal metastases is affected by a non-negligible recurrence rate. The earlier the recurrence, the worse the prognosis. We analyzed an unexplored topic, i.e., the incidence, predictive...